STAT News · Scour

For heart health, low-carb or low-fat diet works, as long as it’s high quality: study

statnews.com·13w

STAT+: The unusual Prasad missive in the FDA’s rejection of the Moderna flu shot application

statnews.com·13w

STAT+: Pharmalittle: We’re reading about FDA rejecting a Moderna vaccine, compounding in the crosshairs and more

statnews.com·13w

Confidence in safety of certain vaccines is dropping

statnews.com·13w

STAT+: Hims is in the crosshairs. Is a crackdown coming for compounding?

statnews.com·13w

STAT+: Biotechs, wary of being tied to Big Pharma, form new industry group as hedge against Trump policies

statnews.com·13w

Opinion: My granddaughter has a rare disease. But clinical trials often exclude patients like her

statnews.com·13w

Opinion: How AI is making me a better clinical psychologist

statnews.com·13w

STAT+: Novartis’ biomedical research head on AI, pruning the pipeline, and a potential blockbuster

statnews.com·13w

STAT+: FDA refuses to review Moderna’s influenza vaccine

statnews.com·13w

We tested the government’s official new A.I. nutrition tool: Grok

statnews.com·13w

Landmark settlement could create new protections for harm reduction under disability law

statnews.com·13w

STAT+: Abridge CTO on Epic and what’s after AI scribing

statnews.com·13w

STAT+: TrumpRx: Hype or real savings?

statnews.com·13w

STAT+: Evommune reports positive mid-stage data for eczema drug

statnews.com·13w

STAT+: Trump administration revives effort to launch pilot initiative reworking drug discount program

statnews.com·13w

STAT+: Pharmalittle: We’re reading about FDA rejecting a rare disease drug, a warning to a Hims compounding pharmacy and more

statnews.com·13w

Trump cabinet members watching their diets with RFK Jr.

statnews.com·13w

STAT+: Eczema drug from Nektar Therapeutics maintains skin responses in one-year study

statnews.com·13w

Opinion: The new childhood vaccine guidelines have a paid leave problem

statnews.com·13w

Log in to enable infinite scrolling